Evidence map›Paper›PMID 22077822›Full record

ArticleAIDS research and human retroviruses2012

Short communication: HIV type 1 escapes inactivation by saliva via rapid escape into oral epithelial cells.

Elizabeth A Dietrich, Kristin H Gebhard, Claudine E Fasching, Rodrigo A Giacaman, John C Kappes, Karen F Ross, Mark C Herzberg

Open access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Taste Dysfunction and Long COVID-19.Frontiers in cellular and infection microbiology · 2021
    Article
  3. Review
  4. Saliva and viral infections.Periodontology 2000 · 2016
    Review
  5. Article
  6. Article
  7. Detecting viruses by using salivary diagnostics.Journal of the American Dental Association (1939) · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Elizabeth A DietrichUniversity of Minnesota School of Dentistry, Minneapolis, MN 55455, USA.
Kristin H Gebhard
Claudine E Fasching
Rodrigo A Giacaman
John C Kappes
Karen F Ross
Mark C Herzberg
University of Minnesota · US

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
Mucosal HIV and Immunobiology CenterR24DK064400 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SMITH, PHILLIP D · 2003 to 2012
$4.8M
Oral Epithelial Cells: Innate Immune "Gatekeeper" of HIVR01DE015503 · NIDCR · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HERZBERG, MARK C · 2003 to 2006
$1.3M
NIAID NIH HHS P30-AI-27767NIDCR NIH HHS R01DE015503NIDCR NIH HHS R21DE015506NIDDK NIH HHS R24 DK064400NIDDK NIH HHS R24 DK-64400
6 · The paper itself

Abstract

Saliva contains anti-HIV-1 factors, which show unclear efficacy in thwarting mucosal infection. When incubated in fresh, unfractionated whole saliva, infectious HIV-1 IIIb and BaL (X4- and R5-tropic, respectively) persisted from 4 to at least 30 min in a saliva concentration-dependent manner. In salivary supernatant for up to 6 h, both infectious HIV-1 strains "escaped" into immortalized oral epithelial cells; infectious BaL showed selectively enhanced escape in the presence of saliva. Fluorescently labeled HIV-1 virus-like particles entered oral epithelial cells within minutes of exposure. Using a previously unrecognized mechanism, therefore, strains of HIV-1 escape inactivation by saliva via rapid uptake into oral epithelial cells.

Indexed as

EndocytosisAdultEpithelial CellsHIV-1HumansMicrobial ViabilitySaliva

Identifiers

PMID22077822
PMCPMC3505059
OpenAlexW2137567408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.